Somchai Yodsanga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Somchai Yodsanga has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Somporn Swasdison
Department of Oral Medicine, College of Dental Medicine, Rangsit University, 52/345 Phahonyothin Rd., Mueang Pathum Thani District, Pathum Thani 12000, Thailand
2 shared publications - Soranun Chantarangsu
Department of Oral Pathology, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand
2 shared publications - Supattra Poeaim
Department of Biology, School of Science, King Mongkut’s Institute of Technology Ladkrabang, Bangkok 10520, Thailand
2 shared publications - Nikos Mattheos
Oral and Maxillofacial Surgery and Digital Implant Surgery Research Unit, Faculty of Dentistry Chulalongkorn University Bangkok Thailand
1 shared publication - Paksinee Kamolratanakul
Department of Oral and Maxillofacial Surgery, Oral and Maxillofacial Surgery and Digital Implant Surgery Research Unit, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand
1 shared publication - Pornchai Jansisyanont
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand
1 shared publication
Latest Publications
- Open Access
Investigation of Biodegradation and Biocompatibility of Chitosan–Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications
Developing scaffolds with a three-dimensional porous structure and adequate mechanical properties remains a key challenge in tissue engineering of bone. These scaffolds must be biocompatible and biodegradable to effectively support osteoblastic cell attachment, metabolic activity, and differentiation. This study successfully fabricated a chitosan–bacterial cellulose (CS–BC) composite scaffold using the solvent casting/particle leaching (SCPL) technique, with NaOH/urea solution and sodium chloride crystals as the porogen. The scaffold exhibited a well-distributed porous network with pore sizes ranging from 300 to 500 µm. Biodegradation tests in PBS containing lysozyme revealed a continuous degradation process, while in vitro studies with MC3T3-E1 cells (pre-osteoblastic mouse cell line) demonstrated excellent cell attachment, as observed through SEM imaging. The scaffold also promoted increased metabolic activity (OD values) in the MTT assay, and enhanced alkaline phosphatase (ALP) activity and upregulated expression of osteogenic-related genes. These findings suggest that the CS–BC composite scaffold, fabricated using the SCPL method, holds great potential as a candidate for bone tissue engineering applications.
Open AccessInvestigation of Biodegradation and Biocompatibility of Chitosan–Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications
Developing scaffolds with a three-dimensional porous structure and adequate mechanical properties remains a key challenge in tissue engineering of bone. These scaffolds must be biocompatible and biodegradable to effectively support osteoblastic cell attachment, metabolic activity, and differentiation. This study successfully fabricated a chitosan–bacterial cellulose (CS–BC) composite scaffold using the solvent casting/particle leaching (SCPL) technique, with NaOH/urea solution and sodium chloride crystals as the porogen. The scaffold exhibited a well-distributed porous network with pore sizes ranging from 300 to 500 µm. Biodegradation tests in PBS containing lysozyme revealed a continuous degradation process, while in vitro studies with MC3T3-E1 cells (pre-osteoblastic mouse cell line) demonstrated excellent cell attachment, as observed through SEM imaging. The scaffold also promoted increased metabolic activity (OD values) in the MTT assay, and enhanced alkaline phosphatase (ALP) activity and upregulated expression of osteogenic-related genes. These findings suggest that the CS–BC composite scaffold, fabricated using the SCPL method, holds great potential as a candidate for bone tissue engineering applications.
- Open Access
- 24 February 2025
- Published by MDPI AG in Preprints.org
Investigation of Biodegradation and Biocompatibility of Chitosan-Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications
Developing scaffolds with a three-dimensional porous structure and adequate mechanical properties remains a key challenge in tissue engineering of bone. These scaffolds must be biocompatible and biodegradable to effectively support osteoblastic cell attachment, proliferation, and differentiation. This study successfully fabricated a chitosan-bacterial cellulose (CS-BC) composite scaffold using the solvent casting/particle leaching (SCPL) technique, with NaOH/urea solution as the solvent and sodium chloride crystals as the porogen. The scaffold exhibited a well-distributed porous network with pore sizes ranging from 300 to 500 µm. Biodegradation tests in PBS containing lysozyme revealed a continuous degradation process, while in vitro studies with pre-osteoblastic MC3T3-E1 cells demonstrated excellent cell attachment, as observed through SEM imaging. The scaffold also promoted cell proliferation, as indicated by increased OD values in the MTT assay, and enhanced ALP activity and upregulated expression of osteogenic-related genes. These findings suggest that the CS-BC composite scaffold, fabricated using the SCPL method, holds great potential as a candidate for bone tissue engineering applications.
- 24 February 2025
- Published by MDPI AG in Preprints.org
Open AccessInvestigation of Biodegradation and Biocompatibility of Chitosan-Bacterial Cellulose Composite Scaffold for Bone Tissue Engineering Applications
Developing scaffolds with a three-dimensional porous structure and adequate mechanical properties remains a key challenge in tissue engineering of bone. These scaffolds must be biocompatible and biodegradable to effectively support osteoblastic cell attachment, proliferation, and differentiation. This study successfully fabricated a chitosan-bacterial cellulose (CS-BC) composite scaffold using the solvent casting/particle leaching (SCPL) technique, with NaOH/urea solution as the solvent and sodium chloride crystals as the porogen. The scaffold exhibited a well-distributed porous network with pore sizes ranging from 300 to 500 µm. Biodegradation tests in PBS containing lysozyme revealed a continuous degradation process, while in vitro studies with pre-osteoblastic MC3T3-E1 cells demonstrated excellent cell attachment, as observed through SEM imaging. The scaffold also promoted cell proliferation, as indicated by increased OD values in the MTT assay, and enhanced ALP activity and upregulated expression of osteogenic-related genes. These findings suggest that the CS-BC composite scaffold, fabricated using the SCPL method, holds great potential as a candidate for bone tissue engineering applications.
- 23 March 2022
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 24 (3) , 361-371
The impact of deproteinized bovine bone particle size on histological and clinical bone healing outcomes in the augmented sinus: A randomized controlled clinical trial
Objective: The effect of different deproteinized bovine bone mineral (DBBM) particle sizes on bone healing in maxillary sinus floor augmentation remains unclear. This study compared the newly formed tissue and angiogenesis‐related bone healing after sinus floor augmentation using large or small DBBM particles.Materials and Methods: Overall 32 patients were randomly divided into two groups using either large (1–2 mm) or small (0.25–1 mm) DBBM particles for sinus floor augmentation. After 6 months, the mineralized tissue volume was calculated using micro‐computed tomography (micro‐CT) analysis. The newly formed tissue composition was histomorphometrically analyzed. Angiogenesis was also examined by means of vascular endothelial growth factor (VEGF) expression. Implant failure and marginal bone loss were measured at a 1‐year follow‐up. Statistical analysis was performed using independent samples t‐test.Results: Micro‐CT analysis demonstrated that grafting with large particles resulted in higher bone volume (6.99 ± 2.72 mm3, p = 0.002) and Bone Volume/Tissue Volume (0.25 ± 0.1, p = 0.03) compared with small particles (3.76 ± 1.83 mm3 and 0.14 ± 0.13, respectively). Small particles showed higher non‐mineralized tissue volume (26.31 mm3) compared with large particle group (17.4 ± 5.34 mm3) with p = 0.001. The histological data revealed significantly higher area of newly formed bone (32.15% ± 14.04% for the large particle and 15.99% ± 14.12% for the small particle groups, p = 0.004). Likewise, non‐mineralized tissue was significantly greater in the small particle group (66.48% ± 20.97%) compared with the large particle group (44.36%, p = 0.016). Moreover, use of large particles resulted in a significantly higher VEGF staining intensity score and VEFG positive cells. No implant failure was recorded in both groups, while no difference was found in terms of marginal bone loss at the 1‐year follow‐up.Conclusions: Sinus floor augmentation using large DBBM particles resulted in more angiogenesis expression, higher bone volume, and new bone formation at 6 months after sinus augmentation. However, clinical outcomes with regards to implant placement were similar in both groups.
- 23 March 2022
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 24 (3) , 361-371
The impact of deproteinized bovine bone particle size on histological and clinical bone healing outcomes in the augmented sinus: A randomized controlled clinical trial
Objective: The effect of different deproteinized bovine bone mineral (DBBM) particle sizes on bone healing in maxillary sinus floor augmentation remains unclear. This study compared the newly formed tissue and angiogenesis‐related bone healing after sinus floor augmentation using large or small DBBM particles.Materials and Methods: Overall 32 patients were randomly divided into two groups using either large (1–2 mm) or small (0.25–1 mm) DBBM particles for sinus floor augmentation. After 6 months, the mineralized tissue volume was calculated using micro‐computed tomography (micro‐CT) analysis. The newly formed tissue composition was histomorphometrically analyzed. Angiogenesis was also examined by means of vascular endothelial growth factor (VEGF) expression. Implant failure and marginal bone loss were measured at a 1‐year follow‐up. Statistical analysis was performed using independent samples t‐test.Results: Micro‐CT analysis demonstrated that grafting with large particles resulted in higher bone volume (6.99 ± 2.72 mm3, p = 0.002) and Bone Volume/Tissue Volume (0.25 ± 0.1, p = 0.03) compared with small particles (3.76 ± 1.83 mm3 and 0.14 ± 0.13, respectively). Small particles showed higher non‐mineralized tissue volume (26.31 mm3) compared with large particle group (17.4 ± 5.34 mm3) with p = 0.001. The histological data revealed significantly higher area of newly formed bone (32.15% ± 14.04% for the large particle and 15.99% ± 14.12% for the small particle groups, p = 0.004). Likewise, non‐mineralized tissue was significantly greater in the small particle group (66.48% ± 20.97%) compared with the large particle group (44.36%, p = 0.016). Moreover, use of large particles resulted in a significantly higher VEGF staining intensity score and VEFG positive cells. No implant failure was recorded in both groups, while no difference was found in terms of marginal bone loss at the 1‐year follow‐up.Conclusions: Sinus floor augmentation using large DBBM particles resulted in more angiogenesis expression, higher bone volume, and new bone formation at 6 months after sinus augmentation. However, clinical outcomes with regards to implant placement were similar in both groups.